Teladoc Stock Price, News & Analysis (NYSE:TDOC)

$38.80 +0.15 (+0.39 %)
(As of 02/23/2018 07:36 AM ET)
Previous Close$38.65
Today's Range$38.30 - $39.75
52-Week Range$19.60 - $39.95
Volume1.27 million shs
Average Volume1.18 million shs
Market Capitalization$2.20 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.49

About Teladoc (NYSE:TDOC)

Teladoc logoTeladoc, Inc. is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company's solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. As of July 17, 2017, it served over 7,500 employers, health plans, health systems and other entities. As of July 17, 2017, these clients collectively purchased access to its solution for more than 20 million Members. As of December 31, 2016, it had over 30 health plans as Clients. Its solutions consist of an integrated technology platform, Provider network, consumer engagement strategies and entrenched distribution channels.

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Telemedicine Services
Sub-IndustryN/A
SectorMedical
SymbolNYSE:TDOC
CUSIPN/A
Phone203-635-2002

Debt

Debt-to-Equity Ratio0.83%
Current Ratio5.08%
Quick Ratio5.08%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$123.16 million
Price / Sales17.97
Cash FlowN/A
Price / CashN/A
Book Value$4.27 per share
Price / Book9.09

Profitability

Trailing EPS($1.44)
Net Income$-74,210,000.00
Net Margins-39.61%
Return on Equity-21.59%
Return on Assets-13.49%

Miscellaneous

Employees670
Outstanding Shares57,050,000

Teladoc (NYSE:TDOC) Frequently Asked Questions

What is Teladoc's stock symbol?

Teladoc trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

How were Teladoc's earnings last quarter?

Teladoc Inc (NYSE:TDOC) posted its quarterly earnings results on Wednesday, November, 1st. The health services provider reported ($0.55) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.30) by $0.25. The health services provider earned $68.70 million during the quarter, compared to the consensus estimate of $67.53 million. Teladoc had a negative net margin of 39.61% and a negative return on equity of 21.59%. The firm's revenue for the quarter was up 112.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.33) earnings per share. View Teladoc's Earnings History.

Where is Teladoc's stock going? Where will Teladoc's stock price be in 2018?

15 brokerages have issued 12-month price targets for Teladoc's shares. Their predictions range from $31.00 to $45.00. On average, they expect Teladoc's share price to reach $39.54 in the next year. View Analyst Ratings for Teladoc.

What are Wall Street analysts saying about Teladoc stock?

Here are some recent quotes from research analysts about Teladoc stock:

  • 1. Cantor Fitzgerald analysts commented, "Best Doctors overview. TDOC closed the acquisition of Best Doctors (BD) in July 2017. BD brings significant capabilities to Teladoc as it pursues its virtual care delivery solution. With BD, the company’s addressable market opportunity almost doubles to $57 billion. BD had about 2.5 million members at the time of the acquisition, with a roughly 600,000 overlap, compared with TDOC’s membership of 20.5 million. Management indicated that BD drives $36,000 in average savings for expert review and $116,000 for critical care cases. Finally, BD indicated that there is a $200 million cross-sell opportunity with TDOC before considering new clients, add-on products and competitive takeaways." (11/20/2017)
  • 2. According to Zacks Investment Research, "The stock of Teladoc has outperformed the industry year to date. The company is witnessing steady business growth with insurers and customers increasingly embracing telehealth. It’s organic growth initiative remains on track. With a number of acquisitions completed since its inception, the company has expanded its distribution capabilities and broadened its service offering. Also the company boasts an impressive clientele. The company has also provided strong guidance for 2017. The company has incurred significant losses in each period since its inception in 2002. Teladoc has been unable to generate cash from operations and we have doubts over its ability to do so in the coming quarters. Its high debt level has caused a spike in interest expense which has dented its operating margins." (10/18/2017)
  • 3. Cowen Inc analysts commented, "We are positive on TDOC's partnership with Accolade as it should help drive utilization for members entitled to both benefits. For clients with the combined offering, it has demonstrated improvements in utilization, with mgmt noting ~30% higher utilization. The partnership is already embedded into 2017 guidance, which gives us incremental comfort in the implied utilization ramp." (3/16/2017)
  • 4. Chardan Capital analysts commented, "After market close on Wed., TDOC reported earnings with a beat and a mixed guide for 2017. For 4Q16, Teladoc beat the Street consensus by 2% on the topline and by $0.04 on the bottom line. Management guided to topline growth in 2017 of 48%, in-line with Street consensus and re-affirmed its target of being adj. EBITDA breakeven in 4Q17. Management also guided to more EBITDA loss in 2017 than the Street expected in the first 3 quarters driven by various investments in growth. We adjust our estimates down slightly and in-line with Management Guidance for 2017. We raise our PT to $28 based on multiple expansion we see in 2017 as TDOC's operating characteristics improve relative to valuation comps and investor confidence grows in the company's execution." (3/2/2017)

Who are some of Teladoc's key competitors?

Who are Teladoc's key executives?

Teladoc's management team includes the folowing people:

  • David B. Snow Jr., Independent Chairman of the Board (Age 62)
  • Peter A. McClennen, President (Age 47)
  • Jason Gorevic, Chief Executive Officer, Director (Age 48)
  • Mark J. Hirschhorn, Chief Financial Officer, Chief Operating Officer, Executive Vice President (Age 52)
  • Peter N. Nieves, Executive Vice President, Chief Revenue Officer (Age 49)
  • Gabriel R. Cappucci, Senior Vice President, Chief Accounting Officer, Controller (Age 54)
  • Michael H. King, Chief Sales Officer (Age 53)
  • Adam C. Vandervoort, Chief Legal Officer and Secretary (Age 42)
  • Helen Darling, Independent Director (Age 75)
  • William H. Frist M.D., Independent Director

When did Teladoc IPO?

(TDOC) raised $112 million in an IPO on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Who owns Teladoc stock?

Teladoc's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.71%), Alliancebernstein L.P. (7.84%), TRIDENT CAPITAL MANAGEMENT-VI, L.L.C. (5.60%), Eagle Asset Management Inc. (4.29%), Bamco Inc. NY (3.39%) and Jennison Associates LLC (3.15%). Company insiders that own Teladoc stock include Adam C Vandervoort, Dana G Jr Mead, James K Outland, Jason N Gorevic, Lp Chp III, Mark Hirschhorn, Michael H King and Trident Capital Fund Vi Lp. View Institutional Ownership Trends for Teladoc.

Who sold Teladoc stock? Who is selling Teladoc stock?

Teladoc's stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Schroder Investment Management Group, Driehaus Capital Management LLC, Kennedy Capital Management Inc., Goldman Sachs Group Inc., Sectoral Asset Management Inc, EAM Investors LLC and Deutsche Bank AG. Company insiders that have sold Teladoc company stock in the last year include Adam C Vandervoort, Jason N Gorevic, Mark Hirschhorn and Michael H King. View Insider Buying and Selling for Teladoc.

Who bought Teladoc stock? Who is buying Teladoc stock?

Teladoc's stock was acquired by a variety of institutional investors in the last quarter, including Carillon Tower Advisers Inc., Champlain Investment Partners LLC, Alliancebernstein L.P., Bamco Inc. NY, Eagle Asset Management Inc., BlackRock Inc., Teachers Advisors LLC and Bainco International Investors. View Insider Buying and Selling for Teladoc.

How do I buy Teladoc stock?

Shares of Teladoc can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Teladoc's stock price today?

One share of Teladoc stock can currently be purchased for approximately $38.80.

How big of a company is Teladoc?

Teladoc has a market capitalization of $2.20 billion and generates $123.16 million in revenue each year. The health services provider earns $-74,210,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis. Teladoc employs 670 workers across the globe.

How can I contact Teladoc?

Teladoc's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]


MarketBeat Community Rating for Teladoc (TDOC)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  311 (Vote Outperform)
Underperform Votes:  156 (Vote Underperform)
Total Votes:  467
MarketBeat's community ratings are surveys of what our community members think about Teladoc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Teladoc (NYSE:TDOC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.792.752.83
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $39.54$39.42$39.09$37.30
Price Target Upside: 4.32% upside14.25% upside24.10% upside23.31% upside

Teladoc (NYSE:TDOC) Consensus Price Target History

Price Target History for Teladoc (NYSE:TDOC)

Teladoc (NYSE:TDOC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/31/2018Canaccord GenuityBoost Price TargetBuy -> Buy$42.00 -> $43.00MediumView Rating Details
1/26/2018Jefferies GroupInitiated CoverageBuy$40.00HighView Rating Details
1/10/2018KeyCorpReiterated RatingBuy$41.00HighView Rating Details
1/4/2018CitigroupInitiated CoverageBuyMediumView Rating Details
12/8/2017Deutsche BankInitiated CoverageBuy -> Buy$39.00LowView Rating Details
11/21/2017CIBCReiterated RatingOutperform -> Outperform$40.00 -> $45.00N/AView Rating Details
11/21/2017OppenheimerBoost Price TargetOutperform$40.00 -> $45.00N/AView Rating Details
11/20/2017Cantor FitzgeraldReiterated RatingHold$31.00N/AView Rating Details
11/3/2017SunTrust BanksReiterated RatingBuy$40.00N/AView Rating Details
9/30/2017CowenReiterated RatingOutperform$39.00MediumView Rating Details
9/29/2017Piper Jaffray CompaniesReiterated RatingBuy$42.00LowView Rating Details
9/18/2017Robert W. BairdDowngradeOutperform -> Neutral$14.00 -> $36.00HighView Rating Details
6/20/2017William BlairReiterated RatingOutperformHighView Rating Details
6/20/2017Chardan CapitalBoost Price TargetBuy -> Buy$30.00 -> $41.00HighView Rating Details
5/12/2017Craig HallumDowngradeBuy -> Hold$28.00 -> $32.00LowView Rating Details
8/28/2016FBR & CoReiterated RatingBuyN/AView Rating Details
6/1/2016Stifel NicolausInitiated CoverageHoldN/AView Rating Details
4/1/2016Leerink SwannReiterated RatingOutperformN/AView Rating Details
3/3/2016Royal Bank of CanadaLower Price TargetOutperform$35.00 -> $20.00N/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Teladoc (NYSE:TDOC) Earnings History and Estimates Chart

Earnings by Quarter for Teladoc (NYSE:TDOC)

Teladoc (NYSE TDOC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017Q3($0.30)($0.55)$67.53 million$68.70 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.26)($0.28)$44.39 million$44.60 millionViewListenView Earnings Details
5/8/2017Q1 2017($0.33)($0.30)$42.22 million$42.90 millionViewListenView Earnings Details
3/1/2017Q416($0.35)($0.31)$36.73 million$37.40 millionViewListenView Earnings Details
10/27/2016Q316($0.36)($0.33)$32.29 million$32.40 millionViewListenView Earnings Details
8/3/2016Q216($0.39)($0.38)$28.20 million$26.50 millionViewN/AView Earnings Details
5/10/2016Q116($0.38)($0.40)$26.64 million$26.90 millionViewListenView Earnings Details
3/2/2016Q415($0.41)($0.39)$21.89 million$22.60 millionViewN/AView Earnings Details
11/2/2015Q315($0.35)($0.35)$19.31 million$19.97 millionViewN/AView Earnings Details
8/12/2015Q215($0.43)($0.46)$17.06 million$18.30 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Teladoc (NYSE:TDOC) Earnings Estimates

2018 EPS Consensus Estimate: ($1.17)
2019 EPS Consensus Estimate: ($0.78)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.48)($0.36)($0.42)
Q2 20183($0.34)($0.19)($0.29)
Q3 20183($0.32)($0.18)($0.25)
Q4 20183($0.27)($0.17)($0.21)
Q1 20192($0.24)($0.23)($0.24)
Q2 20192($0.22)($0.18)($0.20)
Q3 20192($0.19)($0.18)($0.19)
Q4 20192($0.22)($0.10)($0.16)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Teladoc (NYSE:TDOC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Teladoc (NYSE TDOC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.47%
Insider Trades by Quarter for Teladoc (NYSE:TDOC)
Institutional Ownership by Quarter for Teladoc (NYSE:TDOC)

Teladoc (NYSE TDOC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/4/2017Jason N GorevicCEOSell100,000$32.99$3,299,000.00718,261View SEC Filing  
12/4/2017Mark HirschhornCFOSell30,000$32.99$989,700.005,203View SEC Filing  
11/2/2017Jason N GorevicCEOSell20,000$32.10$642,000.00838,261View SEC Filing  
10/17/2017Mark HirschhornVPSell35,000$32.84$1,149,400.0020,887View SEC Filing  
10/16/2017Mark HirschhornCFOSell25,000$32.37$809,250.0020,887View SEC Filing  
10/2/2017Jason N GorevicCEOSell20,000$33.47$669,400.00View SEC Filing  
10/2/2017Mark HirschhornVPSell10,000$34.04$340,400.00View SEC Filing  
9/22/2017Mark HirschhornVPSell25,000$31.93$798,250.0064,987View SEC Filing  
8/7/2017Adam C VandervoortInsiderSell53,806$30.92$1,663,681.5233,008View SEC Filing  
6/6/2017Jason N GorevicCEOSell19,991$32.89$657,503.99831,650View SEC Filing  
6/5/2017Jason N GorevicCEOSell13,389$32.89$440,364.21831,650View SEC Filing  
5/25/2017Jason N GorevicCEOSell5,600$29.57$165,592.00823,861View SEC Filing  
5/23/2017Jason N GorevicCEOSell14,400$29.57$425,808.00822,961View SEC Filing  
5/17/2017Mark HirschhornVPSell100,000$27.70$2,770,000.0080,887View SEC Filing  
5/8/2017Jason N GorevicCEOSell15,000$23.11$346,650.00833,261View SEC Filing  
4/19/2017Mark HirschhornVPSell59,100$25.46$1,504,686.00180,887View SEC Filing  
4/19/2017Michael H KingInsiderSell5,000$25.75$128,750.0061,459View SEC Filing  
1/26/2017Mark HirschhornVPSell900$20.00$18,000.00239,987View SEC Filing  
1/24/2017Jason N GorevicCEOSell100,000$15.79$1,579,000.00926,158View SEC Filing  
1/24/2017Trident Capital Fund Vi LpMajor ShareholderSell250,000$15.79$3,947,500.00View SEC Filing  
1/19/2017Michael H KingInsiderSell5,000$19.00$95,000.0066,459View SEC Filing  
1/17/2017Mark HirschhornVPSell10,000$17.84$178,400.00240,887View SEC Filing  
1/9/2017Mark HirschhornVPSell5,000$17.50$87,500.00250,887View SEC Filing  
12/15/2016Mark HirschhornVPSell5,000$16.60$83,000.00255,887View SEC Filing  
12/14/2016Lp Chp IIIMajor ShareholderSell500,000$16.36$8,180,000.00View SEC Filing  
11/16/2016Mark HirschhornVPSell10,000$17.19$171,900.00258,387View SEC Filing  
11/10/2016Mark HirschhornVPSell5,000$17.50$87,500.00267,687View SEC Filing  
10/17/2016Mark HirschhornVPSell5,000$15.52$77,600.00268,387View SEC Filing  
8/16/2016Jason N GorevicCEOSell40,000$17.92$716,800.00967,258View SEC Filing  
8/11/2016Michael H KingInsiderSell25,000$17.20$430,000.0091,459View SEC Filing  
8/8/2016Adam C VandervoortInsiderSell52,865$16.64$879,673.6046,685View SEC Filing  
8/2/2016James K OutlandDirectorSell10,000$18.00$180,000.0049,089View SEC Filing  
7/15/2016Jason N GorevicCEOSell5,000$15.45$77,250.00932,258View SEC Filing  
6/29/2016James K OutlandDirectorSell10,000$15.00$150,000.0059,089View SEC Filing  
6/29/2016Jason N GorevicCEOSell5,000$15.01$75,050.00932,258View SEC Filing  
3/17/2016Dana G Jr. MeadDirectorBuy10,000$10.65$106,500.0090View SEC Filing  
9/10/2015William H FristDirectorBuy4,500$22.54$101,430.004,500View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Teladoc (NYSE TDOC) News Headlines

Source:
DateHeadline
This Health Care Stock Hits Buy Zone On Flu, Medicare LawThis Health Care Stock Hits Buy Zone On Flu, Medicare Law
finance.yahoo.com - February 22 at 5:48 PM
In Midst of Flu Epidemic, Teladoc Provides Relief for Overburdened Health System - GlobeNewswire (press release)In Midst of Flu Epidemic, Teladoc Provides Relief for Overburdened Health System - GlobeNewswire (press release)
globenewswire.com - February 21 at 8:11 AM
In Midst of Flu Epidemic, Teladoc Provides Relief for Overburdened Health SystemIn Midst of Flu Epidemic, Teladoc Provides Relief for Overburdened Health System
finance.yahoo.com - February 20 at 5:53 PM
Teladoc Inc (TDOC) Expected to Post Quarterly Sales of $76.14 MillionTeladoc Inc (TDOC) Expected to Post Quarterly Sales of $76.14 Million
www.americanbankingnews.com - February 20 at 4:17 PM
Pre-Market Technical Scan on Healthcare Information Services Equities -- Teladoc, athenahealth, Evolent Health, and ... - PR Newswire (press release)Pre-Market Technical Scan on Healthcare Information Services Equities -- Teladoc, athenahealth, Evolent Health, and ... - PR Newswire (press release)
www.prnewswire.com - February 20 at 8:04 AM
Teladoc Inc (TDOC) Expected to Post Earnings of -$0.41 Per ShareTeladoc Inc (TDOC) Expected to Post Earnings of -$0.41 Per Share
www.americanbankingnews.com - February 18 at 1:10 AM
Teladoc: Dilutive, With Too Little UpsideTeladoc: Dilutive, With Too Little Upside
seekingalpha.com - February 15 at 5:31 PM
Teladoc to Announce Fourth Quarter and Full-Year 2017 Financial Results - GlobeNewswire (press release)Teladoc to Announce Fourth Quarter and Full-Year 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - February 14 at 8:00 AM
Teladoc to Announce Fourth Quarter and Full-Year 2017 Financial ResultsTeladoc to Announce Fourth Quarter and Full-Year 2017 Financial Results
finance.yahoo.com - February 13 at 3:32 PM
Congress Boosts Medicare Coverage For Virtual Doctor VisitsCongress Boosts Medicare Coverage For Virtual Doctor Visits
finance.yahoo.com - February 11 at 8:01 AM
Cramer Remix: What could trigger a new wave of selling ne...Cramer Remix: What could trigger a new wave of selling ne...
finance.yahoo.com - February 10 at 7:52 AM
Corporate Leaders Receive Eighteenth Annual Emerald Asset Management “E-3 Awards”Corporate Leaders Receive Eighteenth Annual Emerald Asset Management “E-3 Awards”
finance.yahoo.com - February 6 at 3:32 PM
Teladoc (TDOC) Upgraded at ValuEngineTeladoc (TDOC) Upgraded at ValuEngine
www.americanbankingnews.com - February 4 at 11:46 AM
$76.14 Million in Sales Expected for Teladoc Inc (TDOC) This Quarter$76.14 Million in Sales Expected for Teladoc Inc (TDOC) This Quarter
www.americanbankingnews.com - February 3 at 1:40 PM
Teladoc Inc (TDOC) Given Average Recommendation of "Buy" by BrokeragesTeladoc Inc (TDOC) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - February 3 at 9:50 AM
Teladoc (TDOC) Price Target Raised to $43.00 at Canaccord GenuityTeladoc (TDOC) Price Target Raised to $43.00 at Canaccord Genuity
www.americanbankingnews.com - January 31 at 2:50 PM
Teladoc (TDOC) Now Covered by Analysts at Jefferies GroupTeladoc (TDOC) Now Covered by Analysts at Jefferies Group
www.americanbankingnews.com - January 27 at 11:06 AM
Healthcare: Is Celgene Going to Buy Juno Therapeutics?Healthcare: Is Celgene Going to Buy Juno Therapeutics?
finance.yahoo.com - January 18 at 7:18 PM
FY2017 EPS Estimates for Teladoc Inc (TDOC) Cut by Cantor FitzgeraldFY2017 EPS Estimates for Teladoc Inc (TDOC) Cut by Cantor Fitzgerald
www.americanbankingnews.com - January 15 at 1:12 AM
William Blair Weighs in on Teladoc Incs FY2017 Earnings (TDOC)William Blair Weighs in on Teladoc Inc's FY2017 Earnings (TDOC)
www.americanbankingnews.com - January 12 at 6:26 AM
Research Analysts Issue Forecasts for Teladoc Incs Q1 2019 Earnings (TDOC)Research Analysts Issue Forecasts for Teladoc Inc's Q1 2019 Earnings (TDOC)
www.americanbankingnews.com - January 11 at 10:26 PM
Oppenheimer Weighs in on Teladoc Incs FY2017 Earnings (TDOC)Oppenheimer Weighs in on Teladoc Inc's FY2017 Earnings (TDOC)
www.americanbankingnews.com - January 11 at 7:44 AM
Equities Analysts Offer Predictions for Teladoc Incs FY2017 Earnings (TDOC)Equities Analysts Offer Predictions for Teladoc Inc's FY2017 Earnings (TDOC)
www.americanbankingnews.com - January 11 at 7:44 AM
FY2017 EPS Estimates for Teladoc Inc (TDOC) Decreased by AnalystFY2017 EPS Estimates for Teladoc Inc (TDOC) Decreased by Analyst
www.americanbankingnews.com - January 11 at 7:44 AM
FY2017 EPS Estimates for Teladoc Inc Raised by Analyst (TDOC)FY2017 EPS Estimates for Teladoc Inc Raised by Analyst (TDOC)
www.americanbankingnews.com - January 10 at 6:30 AM
Teladoc Provides Strong Preliminary Results & 2018 OutlookTeladoc Provides Strong Preliminary Results & 2018 Outlook
www.zacks.com - January 9 at 3:49 PM
Why Teladoc Inc. Stock Fell MondayWhy Teladoc Inc. Stock Fell Monday
finance.yahoo.com - January 9 at 3:49 PM
Teladoc Inc (TDOC) Receives Average Rating of "Buy" from BrokeragesTeladoc Inc (TDOC) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - January 9 at 11:52 AM
Teladoc Announces Commercial Availability of Integrated Teladoc - Best Doctors Mobile App Experience - GlobeNewswire (press release)Teladoc Announces Commercial Availability of Integrated Teladoc - Best Doctors Mobile App Experience - GlobeNewswire (press release)
globenewswire.com - January 9 at 11:02 AM
BRIEF-Teladoc Sees 2017 Total Revenues Increase About 88% Over 2016BRIEF-Teladoc Sees 2017 Total Revenues Increase About 88% Over 2016
www.reuters.com - January 8 at 3:52 PM
Teladoc Completes Record Visit Volume in 2017; Provides Preliminary Unaudited 2017 Results and 2018 Financial ... - GlobeNewswire (press release)Teladoc Completes Record Visit Volume in 2017; Provides Preliminary Unaudited 2017 Results and 2018 Financial ... - GlobeNewswire (press release)
globenewswire.com - January 8 at 8:46 AM
Teladoc Completes Record Visit Volume in 2017; Provides Preliminary Unaudited 2017 Results and 2018 Financial OutlookTeladoc Completes Record Visit Volume in 2017; Provides Preliminary Unaudited 2017 Results and 2018 Financial Outlook
finance.yahoo.com - January 8 at 8:46 AM
Keep Your Eye on Twitter This YearKeep Your Eye on Twitter This Year
finance.yahoo.com - January 6 at 8:15 AM
Teladoc (TDOC) Coverage Initiated by Analysts at CitigroupTeladoc (TDOC) Coverage Initiated by Analysts at Citigroup
www.americanbankingnews.com - January 4 at 7:44 AM
ValuEngine Upgrades Teladoc (TDOC) to "Hold"ValuEngine Upgrades Teladoc (TDOC) to "Hold"
www.americanbankingnews.com - January 1 at 9:14 AM
$76.05 Million in Sales Expected for Teladoc Inc (TDOC) This Quarter$76.05 Million in Sales Expected for Teladoc Inc (TDOC) This Quarter
www.americanbankingnews.com - December 31 at 5:58 PM
Zacks: Analysts Anticipate Teladoc Inc (TDOC) to Announce -$0.42 EPSZacks: Analysts Anticipate Teladoc Inc (TDOC) to Announce -$0.42 EPS
www.americanbankingnews.com - December 29 at 8:16 AM
ETFs with exposure to Teladoc, Inc. : December 28, 2017ETFs with exposure to Teladoc, Inc. : December 28, 2017
finance.yahoo.com - December 28 at 2:32 PM
Teladoc Inc (TDOC) Given Average Rating of "Buy" by AnalystsTeladoc Inc (TDOC) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - December 15 at 8:45 AM
Zacks: Analysts Expect Teladoc Inc (TDOC) Will Announce Earnings of -$0.42 Per ShareZacks: Analysts Expect Teladoc Inc (TDOC) Will Announce Earnings of -$0.42 Per Share
www.americanbankingnews.com - December 12 at 3:22 AM
Teladoc (TDOC) Coverage Initiated at Deutsche BankTeladoc (TDOC) Coverage Initiated at Deutsche Bank
www.americanbankingnews.com - December 8 at 11:12 PM
Teladoc Scores Relative Strength Rating UpgradeTeladoc Scores Relative Strength Rating Upgrade
finance.yahoo.com - December 8 at 11:30 AM
Teladoc, Inc. breached its 50 day moving average in a Bearish Manner : TDOC-US : December 7, 2017Teladoc, Inc. breached its 50 day moving average in a Bearish Manner : TDOC-US : December 7, 2017
finance.yahoo.com - December 7 at 11:44 AM
Teladoc, Inc. (TDOC) CFO Sells $989,700.00 in StockTeladoc, Inc. (TDOC) CFO Sells $989,700.00 in Stock
www.americanbankingnews.com - December 4 at 6:10 PM
Insider Selling: Teladoc, Inc. (TDOC) CEO Sells 100,000 Shares of StockInsider Selling: Teladoc, Inc. (TDOC) CEO Sells 100,000 Shares of Stock
www.americanbankingnews.com - December 4 at 5:48 PM
Teladocs (TDOC) "Buy" Rating Reaffirmed at KeyCorpTeladoc's (TDOC) "Buy" Rating Reaffirmed at KeyCorp
www.americanbankingnews.com - December 4 at 12:32 PM
Teladoc Adds New Health System Clients, Achieving 2017 Growth in Excess of 100%Teladoc Adds New Health System Clients, Achieving 2017 Growth in Excess of 100%
finance.yahoo.com - December 4 at 11:39 AM
Teladoc Target of Unusually Large Options Trading (TDOC)Teladoc Target of Unusually Large Options Trading (TDOC)
www.americanbankingnews.com - December 2 at 7:44 AM
After-Hours Stock Movers 11/28: (RGC) (NUAN) Higher; (WAIR) (ADSK) (TDOC) Lower (more...)After-Hours Stock Movers 11/28: (RGC) (NUAN) Higher; (WAIR) (ADSK) (TDOC) Lower (more...)
www.streetinsider.com - November 30 at 3:46 PM
Teladoc Announces Proposed Sale of Shares of Common Stock - GlobeNewswire (press release)Teladoc Announces Proposed Sale of Shares of Common Stock - GlobeNewswire (press release)
globenewswire.com - November 29 at 3:47 PM

SEC Filings

Teladoc (NYSE:TDOC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Teladoc (NYSE:TDOC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Teladoc (NYSE TDOC) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.